AAAAAA

   
Results: 1-14 |
Results: 14
LIVER AND KIDNEY-TRANSPLANTATION FOR POLYCYSTIC DISEASE
Authors: JEYARAJAH DR GONWA TA TESTA G ABBASOGLU O GOLDSTEIN R HUSBERG BS LEVY MF KLINTMALM GB
Citation: Dr. Jeyarajah et al., LIVER AND KIDNEY-TRANSPLANTATION FOR POLYCYSTIC DISEASE, Transplantation, 66(4), 1998, pp. 529-532
THE SAFETY OF CARDIAC OPERATIONS IN THE LIVER-TRANSPLANT RECIPIENT
Authors: PRABHAKAR G TESTA G ABBASOGLU O JEYARAJAH DR GOLDSTEIN RM LEVY MF HUSBERG BS GONWA TA KLINTMALM GB
Citation: G. Prabhakar et al., THE SAFETY OF CARDIAC OPERATIONS IN THE LIVER-TRANSPLANT RECIPIENT, The Annals of thoracic surgery, 65(4), 1998, pp. 1060-1064
GUIDELINES FOR SURGICAL-PROCEDURES AFTER LIVER-TRANSPLANTATION
Authors: TESTA G GOLDSTEIN RM TOUGHANIPOUR A ABBASOGLU O JEYARAJAH DR LEVY MF HUSBERG BS GONWA TA KLINTMALM GB
Citation: G. Testa et al., GUIDELINES FOR SURGICAL-PROCEDURES AFTER LIVER-TRANSPLANTATION, Annals of surgery, 227(4), 1998, pp. 590-599
COMBINED LIVER-KIDNEY TRANSPLANTATION - WHAT ARE THE INDICATIONS
Authors: JEYARAJAH DR MCBRIDE M KLINTMALM GB GONWA TA
Citation: Dr. Jeyarajah et al., COMBINED LIVER-KIDNEY TRANSPLANTATION - WHAT ARE THE INDICATIONS, Transplantation, 64(8), 1997, pp. 1091-1096
HEPATORENAL-SYNDROME - COMBINED LIVER-KIDNEY TRANSPLANTS VERSUS ISOLATED LIVER-TRANSPLANT
Authors: JEYARAJAH DR GONWA TA MCBRIDE M TESTA G ABBASOLGU O HUSBERG BS LEVY MF GOLDSTEIN RM KLINTMALM GB
Citation: Dr. Jeyarajah et al., HEPATORENAL-SYNDROME - COMBINED LIVER-KIDNEY TRANSPLANTS VERSUS ISOLATED LIVER-TRANSPLANT, Transplantation, 64(12), 1997, pp. 1760-1765
10 YEARS OF LIVER-TRANSPLANTATION - AN EVOLVING UNDERSTANDING OF LATEGRAFT LOSS
Authors: ABBASOGLU O LEVY MF BRKIC BB TESTA G JEYARAJAH DR GOLDSTEIN RM HUSBERG BS GONWA TA KLINTMALM GB
Citation: O. Abbasoglu et al., 10 YEARS OF LIVER-TRANSPLANTATION - AN EVOLVING UNDERSTANDING OF LATEGRAFT LOSS, Transplantation, 64(12), 1997, pp. 1801-1807
CHANGES IN URINARY CYTOKINE MESSENGER-RNA PROFILE AFTER SUCCESSFUL THERAPY FOR ACUTE CELLULAR RENAL-ALLOGRAFT REJECTION
Authors: JEYARAJAH DR KADAKIA RA OTOOLE K NEWELL KA JOSEPHSON MA SPARGO BH WOODLE ES THISTLETHWAITE JR
Citation: Dr. Jeyarajah et al., CHANGES IN URINARY CYTOKINE MESSENGER-RNA PROFILE AFTER SUCCESSFUL THERAPY FOR ACUTE CELLULAR RENAL-ALLOGRAFT REJECTION, Transplantation proceedings, 27(1), 1995, pp. 887-889
PROLONGATION OF SKIN XENOGRAFT SURVIVAL WITH CONCOMITANT DONOR BONE-MARROW TRANSPLANTATION
Authors: JEYARAJAH DR SCHMEISSER FS KADAKIA RA THISTLETHWAITE JR
Citation: Dr. Jeyarajah et al., PROLONGATION OF SKIN XENOGRAFT SURVIVAL WITH CONCOMITANT DONOR BONE-MARROW TRANSPLANTATION, Transplantation proceedings, 26(3), 1994, pp. 1201-1202
LOW-DOSE ANTI-CD3 THERAPY PROVIDES LONG-TERM GRAFT-SURVIVAL IN A LEWIS RAT TO C57BL 6 XENO-ISLET TRANSPLANTATION MODEL/
Authors: JEYARAJAH DR SCHMEISSER FS JOSEPHSON MA SOHN DG THISTLETHWAITE JR
Citation: Dr. Jeyarajah et al., LOW-DOSE ANTI-CD3 THERAPY PROVIDES LONG-TERM GRAFT-SURVIVAL IN A LEWIS RAT TO C57BL 6 XENO-ISLET TRANSPLANTATION MODEL/, Transplantation proceedings, 26(2), 1994, pp. 771-773
A NON-ACTIVATING HUMANIZED ANTI-CD3 MONOCLONAL-ANTIBODY RETAINS IMMUNOSUPPRESSIVE PROPERTIES IN-VIVO
Authors: ALEGRE ML PETERSON LJ XU DL SATTAR HA JEYARAJAH DR KOWALKOWSKI K THISTLETHWAITE JR ZIVIN RA JOLLIFFE L BLUESTONE JA
Citation: Ml. Alegre et al., A NON-ACTIVATING HUMANIZED ANTI-CD3 MONOCLONAL-ANTIBODY RETAINS IMMUNOSUPPRESSIVE PROPERTIES IN-VIVO, Transplantation, 57(11), 1994, pp. 1537-1543
SEVERE COMBINED IMMUNODEFICIENT MICE ENGRAFTED WITH HUMAN SPLENOCYTESHAVE FUNCTIONAL HUMAN T-CELLS AND REJECT HUMAN ALLOGRAFTS
Authors: ALEGRE ML PETERSON LJ JEYARAJAH DR WEISER M BLUESTONE JA THISTLETHWAITE JR
Citation: Ml. Alegre et al., SEVERE COMBINED IMMUNODEFICIENT MICE ENGRAFTED WITH HUMAN SPLENOCYTESHAVE FUNCTIONAL HUMAN T-CELLS AND REJECT HUMAN ALLOGRAFTS, The Journal of immunology, 153(6), 1994, pp. 2738-2749
INHIBITION OF T-CELL ACTIVATION BY A MONOCLONAL-ANTIBODY REACTIVE AGAINST THE ALPHA-3 DOMAIN OF HUMAN MHC CLASS-I MOLECULES
Authors: SMITH DM BLUESTONE JA JEYARAJAH DR NEWBERG MH ENGELHARD VH THISTLETHWAITE JR WOODLE ES
Citation: Dm. Smith et al., INHIBITION OF T-CELL ACTIVATION BY A MONOCLONAL-ANTIBODY REACTIVE AGAINST THE ALPHA-3 DOMAIN OF HUMAN MHC CLASS-I MOLECULES, The Journal of immunology, 153(3), 1994, pp. 1054-1067
GENERAL-ASPECTS OF CYTOKINE-RELEASE SYNDROME - TIMING AND INCIDENCE OF SYMPTOMS
Authors: JEYARAJAH DR THISTLETHWAITE JR
Citation: Dr. Jeyarajah et Jr. Thistlethwaite, GENERAL-ASPECTS OF CYTOKINE-RELEASE SYNDROME - TIMING AND INCIDENCE OF SYMPTOMS, Transplantation proceedings, 25(2), 1993, pp. 16-20
HUMAN T-LYMPHOCYTE ACTIVATION IN RESPONSE TO ANTI-CD3 MONOCLONAL-ANTIBODY, ALLOANTIGEN OR ZENOANTIGEN IS INHIBITED BY A MONOCLONAL ANTI-HLACLASS-I REACTIVE ANTIBODY
Authors: SMITH DM JEYARAJAH DR HUSSAIN S WOODLE ES THISTLETHWAITE JR BLUESTONE JA
Citation: Dm. Smith et al., HUMAN T-LYMPHOCYTE ACTIVATION IN RESPONSE TO ANTI-CD3 MONOCLONAL-ANTIBODY, ALLOANTIGEN OR ZENOANTIGEN IS INHIBITED BY A MONOCLONAL ANTI-HLACLASS-I REACTIVE ANTIBODY, The Journal of immunology, 150(8), 1993, pp. 269-269
Risultati: 1-14 |